By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Developing and commercializing medications for the treatment of dermatologic diseases, including35.58M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States35.58M100.00%